ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

University of Rochester Medical Center, Rochester

Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Milan

West Virginia University Eye Institute, Morgantown

University Hospital Ramon y Cajal, Madrid

University of Miami Miller School of Medicine Bascom Palmer Eye Institute, Miami

Universitat Duisburg-Essen, Duisburg

University of Michigan - Kellogg Eye Center, Ann Arbor

University of Iowa Hospitals & Clinics - Eye Clinic, Iowa City

Universitätsmedizin Mainz, Mainz

Mayo Clinic, Rochester

Unità Operativa di Endocrinologia 2, Azienda Ospedaliero-Universitaria Pisana, Pisa

Orbitazentrum Frankfurt, Frankfurt am Main

Washington University School of Medicine - Center for Advanced Medicine (CAM) - Eye Center, St Louis

Eye Wellness Center, Houston

Eyelid Center of Utah, Salt Lake City

Multispecialty Aesthetic Clinical Research Organziation (MACRO), Beverly Hills

Doheny Eye Center UCLA, Pasadena

ARNAS Garibaldi, Presidio di Nesima, Palermo

Oregon Health & Science University (OHSU) - Casey Eye Institute (CEI)-Marquam Hill, Portland

University of British Columbia, Vancouver

Toronto Retina Institute, North York

University of Ottawa Eye Institute, Ottawa

Ophthalmology University Center- Hôpital Maisonneuve-Rosemont, Montreal

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Centro de Oftalmologia Barraquer, Barcelona